We have shown that sole treatment of compounds antagonizing oncogenic mutant SmoM2 effectively inhibited Gli expression and pancreatic cancer cell proliferation in vitro (Fig. 4). This evidence concerns the gene GLI1 and familial pancreatic carcinoma.